Blue Trust’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Blue Trust's HALO Position: Q3 2026 in Review
Blue Trust reduced its Halozyme (HALO) stake by 79% in Q3 2026, selling an estimated $12.1K and leaving 33 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.
Blue Trust first reported a position in HALO in Q2 2022 and has held it in 13 quarters since. The position peaked at $12.4K in Q2 2026. 662 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Blue Trust held 33 shares of Halozyme worth $3.64K as of Q3 2026.
- Blue Trust sold 125 Halozyme shares in Q3 2026, an estimated $12.1K.
- Halozyme made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1916 holding.
- Blue Trust first reported a position in Halozyme in Q2 2022 and has held it in 13 quarters since.
- Blue Trust's Halozyme position peaked at $12.4K in Q2 2026.
- 662 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.